Figure 1. Untreated patients classified according to biomarkers, viral load and HBeAg No liver related complications occurred during the 4-year follow-up among patients with baseline normal FibroTest and normal ActiTest.

This new definition had a 100% negative predictive value for liver related complications or death. Using the classical definition of inactive carrier with normal transaminases, 23% had presumed fibrosis, and 3 complications occurred during the follow-up.